New York State Common Retirement Fund’s Insys Therapeutics, Inc. INSY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-22,700
Closed -$105K 3360
2019
Q1
$105K Hold
22,700
﹤0.01% 2941
2018
Q4
$79K Hold
22,700
﹤0.01% 3019
2018
Q3
$229K Hold
22,700
﹤0.01% 2778
2018
Q2
$164K Hold
22,700
﹤0.01% 2968
2018
Q1
$137K Hold
22,700
﹤0.01% 2873
2017
Q4
$218K Hold
22,700
﹤0.01% 2723
2017
Q3
$202K Hold
22,700
﹤0.01% 2772
2017
Q2
$287K Sell
22,700
-1
-0% -$12 ﹤0.01% 2682
2017
Q1
$239K Buy
22,701
+1
+0% +$11 ﹤0.01% 2707
2016
Q4
$209K Hold
22,700
﹤0.01% 2759
2016
Q3
$268K Hold
22,700
﹤0.01% 2643
2016
Q2
$294K Hold
22,700
﹤0.01% 2536
2016
Q1
$363K Hold
22,700
﹤0.01% 2392
2015
Q4
$650K Sell
22,700
-1,808
-7% -$50.1K ﹤0.01% 2189
2015
Q3
$697K Buy
24,508
+1,445
+6% +$53.2K ﹤0.01% 2153
2015
Q2
$828K Buy
+23,063
New +$718K ﹤0.01% 2283
2014
Q4
Sell
-142,800
Closed -$2.77M 2076
2014
Q3
$2.77M Hold
142,800
﹤0.01% 1468
2014
Q2
$2.23M Hold
142,800
﹤0.01% 1622
2014
Q1
$2.96M Buy
+142,800
New +$2.83M ﹤0.01% 1467

Other funds holding INSY

New York State Common Retirement Fund's INSY Position: Q2 2019 in Review

New York State Common Retirement Fund sold out of Insys Therapeutics, Inc. (INSY) in Q2 2019, closing a stake of 22,700 shares — an estimated $105K sold.

New York State Common Retirement Fund first reported a position in INSY in Q1 2014 and held it in 19 quarters. The position peaked at $2.96M in Q1 2014. 16 funds tracked by Wall St. Rank hold INSY as of Q2 2019.

  • New York State Common Retirement Fund reported no remaining Insys Therapeutics, Inc. position as of Q2 2019 after selling out during the quarter.
  • New York State Common Retirement Fund sold 22,700 Insys Therapeutics, Inc. shares in Q2 2019, an estimated $105K.
  • New York State Common Retirement Fund first reported a position in Insys Therapeutics, Inc. in Q1 2014 and held it in 19 quarters.
  • New York State Common Retirement Fund's Insys Therapeutics, Inc. position peaked at $2.96M in Q1 2014.
  • 16 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q2 2019.

Based on New York State Common Retirement Fund's 13F filing for Q2 2019, filed 9 Aug 2019.